José Prados

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression

Gloria Perazzoli, José Prados, Raúl Ortíz et al. · PLoS ONE · 2015 · 187 citations · Full text

Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications

Raúl Ortíz, Gloria Perazzoli, Laura Cabeza et al. · Current Neuropharmacology · 2020 · 161 citations · Full text

Nanotechnology Advances, Engineering, Biomedical Engineering +25

Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil

Mazen M. El‐Hammadi, Á.V. Delgado, Consolación Melguizo et al. · International Journal of Pharmaceutics · 2016 · 144 citations

Nanomedicine, Medicinal Chemistry, Medicine +8

The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview

Francisco Quiñonero, Cristina Mesas, Kevin Doello et al. · Cancer Biology and Medicine · 2019 · 126 citations · Full text

Pathology, Pharmacotherapy, Cancer Biology +20

Non-viral and viral vectors for gene therapy.

Houría Boulaiz, Juan Antonio Marchal, José Prados et al. · PubMed · 2005 · 111 citations

Cell-based Drug Delivery, Gene Therapies, Cell Therapy +14